Top-News

IntelliPharmaCeutics News

Keine aktuellen Kursdaten verfügbar
WKN: A0YC7P
ISIN: CA4581731011
Typ: Aktie

IntelliPharmaCeutics News

16.08.22 - ACCESSWIRE
Intellipharmaceutics Signs an Exclusive License & Supply Agreement with Taro Pharmaceuticals Inc. for Desvenlafaxine Extended-Release Tablets
TORONTO, ON / ACCESSWIRE / August 16, 2022 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical ...
21.07.22 - ACCESSWIRE
Intellipharmaceutics Announces Second Quarter 2022 Results
TORONTO, ON / ACCESSWIRE / July 21, 2022 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical ...
15.07.22 - ACCESSWIRE
Intellipharmaceutics Announces Delay in Filing Second Quarter Results Due July 15, 2022, The Financial Statements Will be Filed By July 21, 2022
TORONTO, ON / ACCESSWIRE / July 15, 2022 / Intellipharmaceutics International Inc. (OTCQB:IPCIF) and (TSX:IPCI) (" Intellipharmaceutics " or the " Company "), a pharmaceutical ...
27.05.22 - ACCESSWIRE
Intellipharmaceutics Reports Director Election Results
TORONTO, ON / ACCESSWIRE / May 27, 2022 / Intellipharmaceutics International Inc. (OTCQB:IPCIF and TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical ...
14.04.22 - ACCESSWIRE
Intellipharmaceutics Announces First Quarter 2022 Results
TORONTO, ON / ACCESSWIRE / April 14, 2022 / Intellipharmaceutics International Inc. (OTCQB:IPCIF) and (TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical ...
28.02.22 - ACCESSWIRE
Intellipharmaceutics Announces Fiscal Year 2021 Results
TORONTO, ON / ACCESSWIRE / February 28, 2022 / Intellipharmaceutics International Inc. (OTCQB:IPCIF and TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical ...
04.02.22 - ACCESSWIRE
Intellipharmaceutics Reports Director Election Results
TORONTO, ON / ACCESSWIRE / February 4, 2022 / Intellipharmaceutics International Inc. (OTCQB:IPCIF) and (TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a ...
22.04.21 - ACCESSWIRE
Intellipharmaceutics Announces Closing of CAD$3.85 Million Non-Brokered Private Placement
TORONTO, ON / ACCESSWIRE / April 22, 2021 / Intellipharmaceutics International Inc. (OTCQB:IPCIF) and (TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical ...
14.04.21 - ACCESSWIRE
Intellipharmaceutics Announces First Quarter 2021 Results
TORONTO, ON / ACCESSWIRE / April 14, 2021 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical ...
01.03.21 - ACCESSWIRE
Intellipharmaceutics Announces Fiscal Year 2020 Results
TORONTO, ON / ACCESSWIRE / March 1, 2021 / Intellipharmaceutics International Inc. (OTCQB:IPCIF) and (TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical ...
23.12.20 - ACCESSWIRE
Intellipharmaceutics Reports Director Election Results
TORONTO, ON / ACCESSWIRE / December 23, 2020 / Intellipharmaceutics International Inc. (OTCQB:IPCIF) (TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical ...
15.12.20 - ACCESSWIRE
Intellipharmaceutics Announces Change in Venue for The Company’s Annual General Meeting Scheduled To Be Held on December 23, 2020
TORONTO, ON / ACCESSWIRE / December 15, 2020 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical ...
15.10.20 - ACCESSWIRE
Intellipharmaceutics Announces Third Quarter 2020 Results
TORONTO, ON / ACCESSWIRE / October 15, 2020 / Intellipharmaceutics International Inc. (OTCQB IPCIF and TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical ...
17.08.20 - PR Newswire
Kahn Swick & Foti, LLC Announces Summary Notice of Proposed Settlement Involving Purchasers of Intellipharmaceutics Common Stock
Kahn Swick & Foti, LLC Announces Summary Notice of Proposed Settlement Involving Purchasers of Intellipharmaceutics Common Stock PR Newswire
15.07.20 - ACCESSWIRE
Intellipharmaceutics Announces Second Quarter 2020 Results
TORONTO, ON / ACCESSWIRE / July 15, 2020 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical ...
02.07.20 - ACCESSWIRE
"Intellipharmaceutics Announces That The Company And Purdue Pharma L.P. et al Have Entered Into A Stipulated Dismissal Agreement To Terminate Purdue Patent Litigation, Subject To Court Approval"
TORONTO, ON / ACCESSWIRE / July 2, 2020 / Intellipharmaceutics International Inc. (OTCQB:IPCIF) (TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical ...
29.05.20 - ACCESSWIRE
Intellipharmaceutics Announces First Quarter 2020 Results
TORONTO, ON / ACCESSWIRE / May 29, 2020 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical ...
09.04.20 - ACCESSWIRE
Intellipharmaceutics Provides Timing of First Quarter 2020 Results
TORONTO, ON / ACCESSWIRE / April 9, 2020 / Intellipharmaceutics International Inc. (OTCQB:IPCIF);(TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical ...
12.10.18 - ACCESSWIRE
Intellipharmaceutics Announces Pricing of $13 Million Upsized Underwritten Public Offering
Intellipharmaceutics International Inc. (NASDAQ: IPCI; TSX: IPCI) (''Intellipharmaceutics'' or the ''Company''), a pharmaceutical company specializing in the research, development ...
10.10.18 - ACCESSWIRE
Intellipharmaceutics Announces Completion of the Clinical Component of Category 2 and 3 Human Abuse Liability Studies for Oxycodone ER
Intellipharmaceutics International Inc. (NASDAQ: IPCI; TSX : IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development ...

Newssuche

Videos

newspaper
08:40 Uhr +24,14%
Technical Trading: Gold Long freitags
Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »